Advances in the genetics of Parkinson's disease

Serena Rosner, Nir Giladi, Avi Orr-Urtreger*

*Corresponding author for this work

Research output: Contribution to journalReview articlepeer-review


Parkinson's disease (PD) is a neurodegenerative disorder affecting a significant proportion of the ageing population. The etiology is unknown and it is likely due to a multifactorial interaction of genes and the environment on the background of ageing. Findings in the last decade suggest that the contribution of genetics to familial forms of PD is much greater than previously appreciated. Twelve loci are now associated with highly penetrant autosomal dominant or recessive PD, and causative mutations have been identified in eight genes with mutation carriers often characterized by a phenotype indistinguishable from idiopathic disease. To date, PD pharmacotherapy is symptomatic only and does not slow disease progression. Understanding how genetic mutations cause familial PD is likely to clarify molecular mechanisms underlying PD in general and will provide a guide for the development of novel therapies, both preventative and palliative, applicable to all forms of parkinsonism. This review outlines the advances in the study of the genetic background of PD and their possible clinical implications.

Original languageEnglish
Pages (from-to)21-34
Number of pages14
JournalActa Pharmacologica Sinica
Issue number1
StatePublished - Jan 2008


  • Genetic background
  • Leucine-rich repeat kinase 2 gene
  • Parkinson's disease


Dive into the research topics of 'Advances in the genetics of Parkinson's disease'. Together they form a unique fingerprint.

Cite this